CVA Family Office LLC Sells 769 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• CVA Family Office LLC reduced its stake in UnitedHealth Group by 31.2%, selling 769 shares, leaving it with 1,693 shares worth $528,000 as of their latest SEC filing.
• Analysts are mixed on UnitedHealth Group; UBS Group maintains a "buy" rating while Bank of America raised its price target to $390, indicating a consensus rating of "Moderate Buy" and a target price of $385.13 among 29 analysts.
• UnitedHealth Group reported earnings of $4.08 per share for the last quarter, missing the expected $4.45, despite a 12.9% year-over-year revenue increase.

CVA Family Office LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,693 shares of the healthcare conglomerate's stock after selling 769 shares during the quarter. CVA Family Office LLC's holdings in UnitedHealth Group were worth $528,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in UNH. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after buying an additional 170 shares in the last quarter. Caitlin John LLC grew its holdings in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management acquired a new position in UnitedHealth Group in the 2nd quarter valued at $1,324,000. Wealth Effects LLC lifted its position in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Finally, Arlington Partners LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $2,229,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on UNH shares. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Bank of America upped their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 8th. KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. Finally, Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $385.13.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $2.33 during mid-day trading on Friday, hitting $362.78. The company had a trading volume of 5,449,714 shares, compared to its average volume of 7,844,579. The company has a market capitalization of $328.56 billion, a price-to-earnings ratio of 15.72, a P/E/G ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's 50-day moving average price is $338.43 and its 200-day moving average price is $338.97.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.